Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2001, Artiman Ventures is a U.S.-based venture capital firm specializing in early-stage investments. The firm focuses on technology and healthcare sectors, although specific metrics regarding fund size or team composition are not disclosed. Artiman Ventures aims to identify and support companies that address significant challenges through advanced technology.
Artiman Ventures invests in pre-seed, seed, and Series A stages, primarily targeting early-stage companies in AI, healthcare, biotech, and SaaS. Their investment thesis emphasizes identifying opportunities that leverage advanced technology to solve pressing problems across these sectors.
Notable portfolio companies include ApplyBoard, an AI-enabled marketplace for international students; Virsec, which secures corporate applications through advanced attack detection; CellMax Life, a precision cancer blood-testing company; and Visby Medical, a developer of a rapid disease diagnostic platform.
Submit your pitch through their form at artiman.com.
Artiman Ventures often leads investment rounds, particularly in early-stage companies where they can provide significant support and guidance.
The firm typically participates in follow-on investments to support portfolio companies as they grow and require additional funding.
Specific details regarding the size of Artiman Ventures' current fund are not publicly available.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.